Comparison of Dapagliflozin, Lobeglitazone, and Its Combination in Efficacy and Safety
Condition: Diabetes Type 2 Interventions: Drug: Dapagliflozin 10mg Tab; Drug: Lobeglitazone 0.5 mg; Drug: Dapagliflozin + Lobeglitazone Sponsor: Seoul National University Bundang Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus Interventions: Drug: LID104; Drug: Dapagliflozin; Drug: Linagliptin Sponsor: EMS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials